Indication

Staph aureus traumatic skin lesion infection

A *Staphylococcus aureus* traumatic skin lesion infection is a secondary acute bacterial skin and skin structure infection (ABSSSI) affecting the epidermis, dermis, or subcutaneous tissues following physical disruption of the cutaneous barrier. Read more about Staph aureus traumatic skin lesion infection

8 drugs 8 manufacturers

Advertisement

Drugs that treat it

Common Staph aureus traumatic skin lesion infection therapies.

Showing 1–8 of 8 drugs

Filter & compare in the drug finder →Opens the drug finder with Staph aureus traumatic skin lesion infection preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Staph aureus traumatic skin lesion infection.

A *Staphylococcus aureus* traumatic skin lesion infection is a secondary acute bacterial skin and skin structure infection (ABSSSI) affecting the epidermis, dermis, or subcutaneous tissues following physical disruption of the cutaneous barrier.

It typically occurs across pediatric and adult populations following mechanical injury, such as lacerations, abrasions, puncture wounds, or burns.

Pathophysiologically, opportunistic colonization or inoculation of *Staphylococcus aureus* leads to local bacterial replication, immune cell recruitment, and tissue destruction mediated by staphylococcal enzymes and exotoxins.

Clinically, this presentation is characterized by cardinal signs of localized inflammation around the wound margins, including expanding erythema, edema, warmth, purulence or serosanguinous drainage, crusting, and localized pain.

Personalize your experience

Follow Staph aureus traumatic skin lesion infection and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it